<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940119-0-00014</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> DATES:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Effective January 19, 1994; written objections and requests for a hearing by February 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=2 --> Addresses:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Submit written objections to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4700 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <CFRNO>21 CFR Part 178</CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 90F&hyph;0257]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=2 --> Agency:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=2 --> Action:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Final rule. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=2 --> Summary:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of 3,5-di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> &hyph;butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> )-trione as an antioxidant for polyester elastomers in contact with dry food and rubber articles intended for repeated use in contact with food. This action is in response to a petition filed by the Ciba-Geigy Corp. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> DATES:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Effective January 19, 1994; written objections and requests for a hearing by February 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=2 --> Addresses:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Submit written objections to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Vir D. Anand, Center for Food Safety and Applied Nutrition (HFS&hyph;216), Food and Drug Administration, 200 C St. SW., Washington, DC 20204, 202&hyph;254&hyph;9500. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> In a notice published in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  of August 28, 1990 (55 FR 35188), FDA announced that a food additive petition (FAP 0B4222) had been filed by Ciba-Geigy Corp., Seven Skyline Dr., Hawthorne, NY 10532&hyph;2188. The petition proposed that &sect;178.2010  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> Antioxidants and/or stabilizers for polymers <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  (21 CFR 178.2010) be amended to provide for the safe use of 3,5-di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> -butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> )-trione as an antioxidant for polyester elastomers in contact with dry food and rubber articles intended for repeated use in contact with food. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> FDA, in its evaluation of the safety of this additive, reviewed the safety of the additive and the chemical impurities that may be present in the additive resulting from its manufacturing process. Although the additive itself has not been shown to cause cancer, it has been found to contain minute amounts of unreacted ethyl acrylate, a carcinogenic reactant used in the manufacture of the additive. Residual amounts of reactants and manufacturing aids, such as ethyl acrylate, are commonly found as contaminants in chemical products, including food additives. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> I. Determination of Safety <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Under section 409(c)(3)(A) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 348(c)(3)(A), the so-called ``general safety clause'' of the statute, a food additive cannot be approved for a particular use unless a fair evaluation of the data available to FDA establishes that the additive is safe for that use. FDA's food additive regulations (21 CFR 170.3(i)) define ``safe'' as ``a reasonable certainty in the minds of competent scientist that the substance is not harmful under the intended conditions of use.'' <!-- PJG 0012 frnewline --> The anticancer or Delaney clause (section 409(c)(3)(A) of the act) further provides that no food additive shall be deemed safe if it is found to induce cancer when ingested by man or animal. Importantly, however, the Delaney clause applies to the additive itself and not to impurities in the additive. That is, where an additive itself has not been shown to cause cancer, but contains a carcinogenic impurity, the additive is properly evaluated under the general safety clause using risk assessment procedures to determine whether there is a reasonable certainty that no harm will result from the proposed use of the additive.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 -->  Scott <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  v.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> FDA <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , 728 F.2d 322 (6th Cir. 1984). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Safety of the Petitioned Use of the Additive <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> FDA estimates that the petitioned use of the additive 3,5-di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )-trione will result in exposure to the additive of no greater than 100 parts per billion (ppb) in the daily diet (Ref. 1). <!-- PJG 0012 frnewline --> FDA does not ordinarily consider chronic toxicological testing to be necessary to determine the safety of an additive whose use will result in such low exposure levels (Ref. 2), and the agency has not required such testing here. However, the agency has reviewed the available toxicological data from acute toxicity studies, subchronic studies, and teratological studies on the additive. No adverse effects were reported in these studies. <!-- PJG 0012 frnewline --> FDA has evaluated the safety of this additive under the general safety clause, considering all available data and using risk assessment procedures to estimate the upper-bound limit of risk presented by ethyl acrylate, a carcinogenic chemical that may be present as an impurity in the additive. This risk evaluation of the carcinogenic impurity ethyl acrylate has two aspects: (1) Assessment of the exposure to the impurity from the proposed use of the additive; and (2) extrapolation of the risk observed in the animal bioassays to the conditions of probable exposure to humans. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Ethyl Acrylate <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Using risk assessment procedures, FDA has estimated the hypothetical worst-case exposure to ethyl acrylate from the petitioned use of the additive in the manufacture of polyester elastomers and rubber articles for repeated use and currently regulated uses to be 380 parts per quadrillion of the daily diet (3 kilograms), or 1 nanogram (ng) per person per day (Ref. 1). The agency used data from the National Toxicology Program report (No. 259: 1986), a bioassay on ethyl acrylate, to estimate the upper-bound limit of lifetime human risk from exposure to this chemical stemming from the proposed use of the additive and the level of ethyl acrylate that may be present in the additive (Ref. 3). The results of the bioassay on ethyl acrylate demonstrated that the material was carcinogenic for rats and mice under the conditions of the study. The test material induced squamous cell neoplasms in both sexes of F344/N rats and B6C3F <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  mice when administered by gavage in corn oil. <!-- PJG 0012 frnewline --> Based on the potential exposure of 1 ng per person per day, FDA estimates that the upper-bound limit of individual lifetime risk from the use of the 3,5-di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )-trione is 8.1x10 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> -11 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , or 8.1 in 100 billion (Ref. 4). Because of the numerous conservatisms in the exposure estimate, the actual lifetime averaged individual exposure to ethyl acrylate is expected to be substantially less than the estimated daily intake, and therefore the calculated upper-bound limit of risk would be less. Thus, the agency concludes that there is a reasonable certainty that no harm from exposure to ethyl acrylate would result from the proposed use of 3,5-di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )-trione. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. Need for Specifications <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The agency has also considered whether a specification is necessary to control the amount of ethyl acrylate impurity in the food additive. The agency finds that a specification is not necessary for the following reasons: (1) Because of the low level at which ethyl acrylate may be expected to remain as an impurity following production of the additive, the agency would not expect this impurity to become a component of food at other than extremely small levels; and (2) the upper-bound limit of lifetime risk from exposure to this impurity, even under worst-case assumptions, is very low, less than 8.1 in 100 billion. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> C. Conclusion on Safety <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> FDA has evaluated data in the petition and other relevant material and concludes that the proposed use of the additive in polyester elastomers in contact with dry food and rubber articles intended for repeated use in contact with food is safe. Based on this information, the agency has also concluded that the additive will have the intended technical effect. Therefore, &sect;178.2010 should be amended as set forth below. <!-- PJG 0012 frnewline --> In accordance with &sect;171.1(h) (21 CFR 171.1(h)), the petition and the documents that FDA considered and relied upon in reaching its decision to approve the petition are available for inspection at the Center for Food Safety and Applied Nutrition by appointment with the information contact person listed above. As provided in 21 CFR 171.1(h), the agency will delete from the documents any materials that are not available for public disclosure before making the documents available for inspection. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> III. Environmental Impact <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the action will not have a significant impact on the human environment, and that an environmental impact statement is not required. The agency's finding of no significant impact and the evidence supporting that finding, contained in an environmental assessment, may be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> IV. Objections <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any person who will be adversely affected by this regulation may at anytime on or before February 18, 1994, file with the Dockets Management Branch (address above) written objection thereto. Each objection shall be separately numbered, and each numbered objection shall specify with particularity the provisions of the regulation to which objection is made and the grounds for the objection. Each numbered objection on which a hearing is requested shall specifically so state. Failure to request a hearing for any particular objection shall constitute a waiver of the right to a hearing on that objection. Each numbered objection for which a hearing is requested shall include a detailed description and analysis of the specific factual information intended to be presented in support of the objection in the event that a hearing is held. Failure to include such a description and analysis for any particular objection shall constitute a waiver of the right to a hearing on the objection. Three copies of all documents shall be submitted and shall be identified with the docket number found in brackets in the heading of this document. Any objection received in response to the regulation may be seen in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> V. References <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The following references have been placed on display in the Dockets Management Branch (address above) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1. Memorandum dated November 9, 1992, from the Food and Color Additive Review Section (HFF&hyph;415), Indirect Additives Branch (HFF&hyph;335), concerning FAP 0B4222 (Ciba-Geigy Corp.) exposure to the food additive and its component (ethyl acrylate). <!-- PJG 0012 frnewline --> 2. Kokoski, C. J., ``Regulatory Food Additive Toxicology,'' in  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Chemical Safety Regulation and Compliance <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , pp. 24&hyph;33, edited by F. Homburger J. K. Marquis, and S. Karger, New York, NY, 1985. <!-- PJG 0012 frnewline --> 3. ``Carcinogenesis Studies of Ethyl Acrylate (CAS Reg. No. 140&hyph;88&hyph;5) in F&hyph;344/N Rats and B6C3F <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=5 f=2 --> 1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Mice'' (gavage studies), National Toxicology Program, Technical Report Series, No. 259, December 1986. <!-- PJG 0012 frnewline --> 4. Memorandum dated April 19, 1993, from the Quantitative Risk Assessment Committee, Center for Food Safety and Applied Nutrition, concerning ethyl acrylate, FAP 0B4222. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects in 21 CFR Part 178 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Food additives, Food packaging. <!-- PJG 0012 frnewline --> Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 178 is amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 178_INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND SANITIZERS <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. The authority citation for 21 CFR part 178 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Secs. 201, 402, 409, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 342, 348, 379e). <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 178.2010 is amended in the table in paragraph (b) for the entry ``3,5-Di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )-trione'' by numerically adding a new entry ``5'' under the heading  <!-- PJG 0012 frnewline --> ``Limitations'' to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;178.2010  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Antioxidants and/or stabilizers for polymers. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (b) * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L1,nj,i1,s80,r50 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Substances  <!-- PJG 007 0150 intable --> 1Limitations <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0163 intable --> 1 <!-- PJG ITAG l=28 g=1 f=1 --> &blank;&blank;*&blank;&blank;&blank;*&blank;&blank;&blank;*&blank;&blank;&blank;*&blank;&blank;&blank;*&blank;&blank; <!-- PJG 007 0163 intable --> 0 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> 3,5-Di- <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> tert <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> -butyl-4-hydroxyhydrocinnamic acid triester with 1,3,5-tris(2-hydroxyethyl)-s-triazine-2,4,6-(1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> ,3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> ,5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> H <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> )-trione (CAS Reg. No. 34137&hyph;09&hyph;2) <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> For use only: <!-- PJG 0012 frnewline -->  <!-- PJG 007 0120 intable --> &blank;* * * <!-- PJG 0012 frnewline -->  <!-- PJG 007 0120 intable --> &blank;5. At levels not to exceed 2 percent by weight of polyester elastomers, complying with &sect;177.1590 of this chapter, in contact with dry food only, and finished rubber articles for repeated use, complying with &sect;177.2600 of this chapter, in contact with all foods, at temperatures not to exceed 150  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=8 f=1 -->  <!-- PJG 0253 grid5678 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> F. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0163 intable --> 1 <!-- PJG /ITAG -->  <!-- PJG ITAG l=28 g=1 f=1 --> &blank;&blank;*&blank;&blank;&blank;*&blank;&blank;&blank;*&blank;&blank;&blank;*&blank;&blank;&blank;*&blank;&blank; <!-- PJG 007 0163 intable --> 0 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: January 12, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Michael R. Taylor, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Commissioner for Policy. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;1154 Filed 1&hyph;18&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F  <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            